Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion

Giulio Bizzozero classified the tissues concerning their capacity to self-renew during the adult life in labile, stable and permanent tissues. In 1940 Viktor Hamburger and Rita Levi Montalcini exposed the possibility to induce the growth of permanent cells thanks to a specific ligand Nerve Growth Factor (NGF). Stanley Cohen purified a protein the Epidermal Growth Factor (EGF), able to induce epidermis proliferation and to elicit precocious eye disclosure and teeth eruption, establishing the “inverse” relationships between the proliferation and differentiation. These two biological effects induced by EGF were according to EGFR signaling is involved in a large array of cellular functions such as proliferation, survival, adhesion, migration and differentiation. This review is focused on the key role of growth factors signaling and their downstream effectors in physiological and in pathological phenomena, the authors highlight the governance of Growth factors during the EMT in cancer invasion.

[1]  A. Giordano,et al.  Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas , 2020, Cancer biology & therapy.

[2]  A. Giordano,et al.  Multifaceted Breast Cancer: The Molecular Connection With Obesity , 2017, Journal of cellular physiology.

[3]  A. Giordano,et al.  Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? , 2016, Journal of cellular physiology.

[4]  E. Rendina,et al.  Cardiosphere Conditioned Media Influence the Plasticity of Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells , 2015, Cell transplantation.

[5]  Isotta Chimenti,et al.  The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells , 2015, BioMed research international.

[6]  W. Woodward,et al.  Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells , 2015, PloS one.

[7]  A. Fiorelli,et al.  Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis. , 2015, The Annals of thoracic surgery.

[8]  G. Pirozzi,et al.  Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma , 2015, Oncoscience.

[9]  A. Giordano,et al.  pRb2/p130 Localizes to the Cytoplasm in Diffuse Gastric Cancer , 2015, Journal of cellular physiology.

[10]  C. Murdoch,et al.  Stem Cell Therapies for Ischemic Cardiovascular Diseases , 2015 .

[11]  A. Porcellini,et al.  The p85 Regulatory Subunit of PI3K Mediates cAMP-PKA and Insulin Biological Effects on MCF-7 Cell Growth and Motility , 2014, TheScientificWorldJournal.

[12]  D. Balciunas,et al.  Extreme Thermal Noxious Stimuli Induce Pain Responses in Zebrafish Larvae , 2014, Journal of cellular physiology.

[13]  R. Franco,et al.  The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. , 2014, Current cancer drug targets.

[14]  G. Tse,et al.  P-cadherin and vimentin are useful basal markers in breast cancers. , 2013, Human pathology.

[15]  R. Franco,et al.  Prognostic implications of node metastatic features in OSCC: a retrospective study on 121 neck dissections. , 2013, Oncology reports.

[16]  H. Lee,et al.  Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. , 2013, Human pathology.

[17]  R. Ralhan,et al.  Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression , 2013, PloS one.

[18]  R. Franco,et al.  BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy , 2013, Journal of Cellular Biochemistry.

[19]  P. Erne,et al.  Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts. , 2013, Cellular signalling.

[20]  D. Fernig,et al.  Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network , 2013, The FEBS journal.

[21]  S. Ceccarelli,et al.  TNFα Modulates Fibroblast Growth Factor Receptor 2 Gene Expression through the pRB/E2F1 Pathway: Identification of a Non-Canonical E2F Binding Motif , 2013, PloS one.

[22]  A. Fiorelli,et al.  The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion. , 2013, Interactive cardiovascular and thoracic surgery.

[23]  M. Vered,et al.  "Is immuno-expression of E-cadherin really a prognostic factor in head and neck cancer?". , 2013, Oral oncology.

[24]  T. Hibi,et al.  Mesenchymal stem cells regulate epithelial–mesenchymal transition and tumor progression of pancreatic cancer cells , 2013, Cancer science.

[25]  G. Botti,et al.  Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs , 2013, Expert opinion on biological therapy.

[26]  W. Seeger,et al.  E-cadherin controls bronchiolar progenitor cells and onset of preneoplastic lesions in mice. , 2012, Neoplasia.

[27]  Wendy Frankel,et al.  The onco-embryonic antigen ROR1 is expressed by a variety of human cancers. , 2012, The American journal of pathology.

[28]  D. Corey,et al.  Structure of a Force-Conveying Cadherin Bond Essential for Inner-Ear Mechanotransduction , 2012, Nature.

[29]  I. Braña,et al.  Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  G. Botti,et al.  pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma , 2012, Cancer biology & therapy.

[31]  L. Perillo,et al.  Cytokines and VEGF Induction in Orthodontic Movement in Animal Models , 2012, Journal of biomedicine & biotechnology.

[32]  T. Kawabe,et al.  Involvement of the transcription factor twist in phenotype alteration through epithelial–mesenchymal transition in lung cancer cells , 2012, Molecular carcinogenesis.

[33]  A. Porcellini,et al.  The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration. , 2012, International journal of oncology.

[34]  Hanmin Wang,et al.  Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells , 2012, PloS one.

[35]  T. Oskarsson,et al.  Extracellular matrix players in metastatic niches , 2012, The EMBO journal.

[36]  Moorthy P Ponnusamy,et al.  Targeting the EGFR signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.

[37]  R Rullo,et al.  Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma. , 2011, Anticancer research.

[38]  A. Fiorelli,et al.  Interplay between steroid receptors and neoplastic progression in sarcoma tumors , 2011, Journal of cellular physiology.

[39]  C. Carratelli,et al.  Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae. , 2011, Cytokine.

[40]  M. Guida,et al.  Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization , 2011, Cancer biology & therapy.

[41]  K. Jones,et al.  Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. , 2011, Cancer research.

[42]  J. Morgado-Díaz,et al.  Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell–cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells , 2011, Cancer Chemotherapy and Pharmacology.

[43]  Y. Luqmani,et al.  Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review). , 2011, International journal of oncology.

[44]  C. Wansleeben,et al.  The planar cell polarity pathway in vertebrate development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[45]  A. Giordano,et al.  Rb family proteins in gastric cancer (review). , 2010, Oncology reports.

[46]  Cathrin Brisken,et al.  Epithelial‐Mesenchymal Transition‐Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells , 2010, Stem cells.

[47]  Wei Li,et al.  Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway , 2010, Breast Cancer Research.

[48]  Zhiwei Wang,et al.  The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. , 2010, Current drug targets.

[49]  Michel Salzet,et al.  Epithelial-mesenchymal transition in ovarian cancer. , 2010, Cancer letters.

[50]  Harald J. Maier,et al.  BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression. , 2010, Genes & cancer.

[51]  Felice-Alessio Bava,et al.  Human colon fibroblasts induce differentiation and proliferation of intestinal epithelial cells through the direct paracrine action of keratinocyte growth factor , 2009, Journal of cellular physiology.

[52]  M. Russo,et al.  Down‐regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells , 2009, Journal of cellular physiology.

[53]  S. Alahari,et al.  Molecular mechanisms controlling E-cadherin expression in breast cancer. , 2009, Biochemical and biophysical research communications.

[54]  Mads Lerdrup,et al.  Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor , 2009, Traffic.

[55]  R. Moon,et al.  Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis , 2009, Cell Research.

[56]  S. Muthuswamy,et al.  ErbB receptors and cell polarity: new pathways and paradigms for understanding cell migration and invasion. , 2009, Experimental cell research.

[57]  Li-Xuan Qin,et al.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. , 2009, Cancer research.

[58]  Y. Kanai Alterations of DNA methylation and clinicopathological diversity of human cancers , 2008, Pathology international.

[59]  P. Speight,et al.  The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma. , 2008, Oral diseases.

[60]  K. Roepstorff,et al.  Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer , 2008, Histochemistry and Cell Biology.

[61]  Christopher S. Chen,et al.  Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion , 2008, Journal of Cell Science.

[62]  Yun Cao,et al.  [Expression and significance of E-cadherin in adenoid cystic carcinoma of the salivary glands]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.

[63]  A. Kinsella,et al.  Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. , 2007, Clinical otolaryngology and allied sciences.

[64]  A. Hall,et al.  Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity , 2007, The Journal of cell biology.

[65]  R. Kalluri,et al.  Mechanisms of metastasis: Epithelial‐to‐mesenchymal transition and contribution of tumor microenvironment , 2007, Journal of cellular biochemistry.

[66]  M. Ferracin,et al.  Regulation of microRNA Expression: the Hypoxic Component , 2007, Cell cycle.

[67]  Wenbin Ye,et al.  MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia , 2006, PloS one.

[68]  S. Bray Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.

[69]  Y. Sugimoto,et al.  Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. , 2006, Anticancer research.

[70]  N. Fukuda,et al.  Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. , 2006, Biochemical and biophysical research communications.

[71]  N. Normanno,et al.  Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application? , 2006, Endocrine-related cancer.

[72]  J. Behrens,et al.  E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. , 2006, Experimental cell research.

[73]  A. García-García,et al.  Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. , 2006, Oral oncology.

[74]  C. Stratakis,et al.  Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. , 2006, The Journal of clinical endocrinology and metabolism.

[75]  Y. Doki,et al.  Overexpression of ADAM9 enhances growth factor-mediated recycling of E-cadherin in human colon cancer cell line HT29 cells. , 2005, Experimental cell research.

[76]  A. Bilancio,et al.  Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. , 2005, Cancer research.

[77]  Alfonso Bellacosa,et al.  Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways , 2005, Oncogene.

[78]  J. Schlessinger,et al.  Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer Interface , 2005, Molecular and Cellular Biology.

[79]  K. Aldape,et al.  PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. , 2005, Human pathology.

[80]  Thomas Kirchner,et al.  Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and β-Catenin , 2005, Cells Tissues Organs.

[81]  S. Weiss,et al.  Wnt-dependent Regulation of the E-cadherin Repressor Snail* , 2005, Journal of Biological Chemistry.

[82]  D. Solter,et al.  Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast , 2004, Development.

[83]  J. Kutok,et al.  Notch Oncoproteins Depend on γ-Secretase/Presenilin Activity for Processing and Function* , 2004, Journal of Biological Chemistry.

[84]  R. Tuan,et al.  Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  Salvatore Pece,et al.  Endocytosis and cancer. , 2004, Current opinion in cell biology.

[86]  Avri Ben-Ze'ev,et al.  Autoregulation of E-cadherin expression by cadherin–cadherin interactions , 2003, The Journal of cell biology.

[87]  Adrian V. Lee,et al.  Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. , 2003, Cancer research.

[88]  M. Russo,et al.  Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER α and β subtypes via an Sp1 site , 2003, Oncogene.

[89]  Keith R. Johnson,et al.  Characterization of Cadherin-24, a Novel Alternatively Spliced Type II Cadherin* , 2003, Journal of Biological Chemistry.

[90]  M. Nagayama,et al.  Downregulation of Wnt4 and upregulation of Wnt5a expression by epithelialmesenchymal transition in human squamous carcinoma cells , 2003, Cancer science.

[91]  A. Buda,et al.  Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis , 2003, Proceedings of the Nutrition Society.

[92]  J. Baselga,et al.  Epithelial growth factor receptor interacting agents. , 2002, Hematology/oncology clinics of North America.

[93]  V. Kosma,et al.  Reduced expression of α-catenin, β-catenin, and γ-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer , 2001, Journal of clinical pathology.

[94]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[95]  S. Mosselman,et al.  Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells. , 2000, Molecular endocrinology.

[96]  M. Ilyas Adhesion molecule expression in breast cancer: the phoenix in tumour metastasis? , 2000, The Journal of pathology.

[97]  F. André,et al.  Integrins and E‐cadherin cooperate with IGF‐I to induce migration of epithelial colonic cells , 1999, International journal of cancer.

[98]  Keith R. Johnson,et al.  N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression , 1999, The Journal of cell biology.

[99]  M. Hendrix,et al.  Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. , 1999, Cancer research.

[100]  R. Kemler,et al.  The C-terminal transactivation domain of β-catenin is necessary and sufficient for signaling by the LEF-1/β-catenin complex in Xenopus laevis , 1999, Mechanisms of Development.

[101]  D. McClay,et al.  Nuclear beta-catenin is required to specify vegetal cell fates in the sea urchin embryo. , 1999, Development.

[102]  M. Quintanilla,et al.  Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[103]  F. Watt,et al.  Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity , 1998, The Journal of pathology.

[104]  A. Børresen-Dale,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression in relation to metastasis in human breast carcinoma , 1998 .

[105]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[106]  T. Carey,et al.  Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion , 1996, The Journal of cell biology.

[107]  P. McCrea,et al.  E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. , 1996, Cancer research.

[108]  M. Monden,et al.  Decreased E‐cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus , 1996, The British journal of surgery.

[109]  S. Nishizuka,et al.  Inactivation of the E‐Cadherin Gene in Primary Gastric Carcinomas and Gastric Carcinoma Cell Lines , 1996, Japanese journal of cancer research : Gann.

[110]  Y. Yarden,et al.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.

[111]  A. Bilancio,et al.  Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. , 1996, Cancer research.

[112]  S. Hirohashi,et al.  E‐Cadherin Gene Mutations in Signet Ring Cell Carcinoma of the Stomach , 1996, Japanese journal of cancer research : Gann.

[113]  R. Yarden,et al.  Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. , 1996, Endocrinology.

[114]  M. Takeichi,et al.  Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. , 1995, Oncogene.

[115]  S. Minoguchi,et al.  Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jκ/Su(H) , 1995, Current Biology.

[116]  Christel Brou,et al.  Signalling downstream of activated mammalian Notch , 1995, Nature.

[117]  J. Feramisco,et al.  Immunohistochemical evaluation of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[118]  J. Spencer,et al.  E-cadherin expression in intestinal epithelium. , 1995, Journal of clinical pathology.

[119]  N. Lemoine,et al.  Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage , 1994, The Journal of pathology.

[120]  Y. Horiguchi,et al.  Cadherins in Cutaneous Biology , 1994, The Journal of dermatology.

[121]  S. Nagata,et al.  Soluble fragments of e-cadherin cell-adhesion molecule increase in urinary-excretion of cancer-patients, potentially indicating its shedding from epithelial tumor-cells. , 1994, International journal of oncology.

[122]  K. Jahnke,et al.  E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. , 1994, Clinical otolaryngology and allied sciences.

[123]  D. Ruiter,et al.  E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome , 1993, International journal of cancer.

[124]  R. Poulsom,et al.  E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. , 1993, The American journal of pathology.

[125]  Frans,et al.  Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene , 1993, The Journal of cell biology.

[126]  M. Oka,et al.  Immunohistochemical detection of desmosomes in oral squamous cell carcinomas: correlation with differentiation, mode of invasion, and metastatic potential. , 1992, International journal of oral and maxillofacial surgery.

[127]  M. Toyota,et al.  Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. , 1992, International journal of oncology.

[128]  W. Birchmeier,et al.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. , 1991, Cancer research.

[129]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[130]  P. Goodfellow,et al.  Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. , 1988, Differentiation; research in biological diversity.

[131]  G. Stancel,et al.  Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. , 1988, Molecular endocrinology.

[132]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[133]  M. Bennett,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.

[134]  L. Frati,et al.  Levels of epidermal growth factor in mice: tissues measured by a specific radioreceptor assay. , 1976, Life sciences.

[135]  L. Frati,et al.  Selective binding of the epidermal growth factor and its specific effects on the epithelial cells of the cornea. , 1972, Experimental eye research.

[136]  L. Frati,et al.  The mechanism of action of the epidermal growth factor. 3. Stimulation of the uptake of labeled precursors into RNA, DNA and proteins induced by EGF in isolated tumor cells. , 1972, Hormones.

[137]  L. Frati,et al.  Synthesis of bioactive 131 I-labeled epidermal growth factor and its distribution in rat tissues. , 1972, European journal of biochemistry.

[138]  S. Cohen,et al.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. , 1962, The Journal of biological chemistry.

[139]  T. Kang,et al.  Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. , 2014, Drug discovery today.

[140]  L. Pierelli,et al.  Optimization of the isolation and expansion method of human mediastinal–adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate , 2013, Cytotechnology.

[141]  A. Al Moustafa,et al.  EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. , 2012, Frontiers in bioscience.

[142]  S. Corvera,et al.  The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells , 2012 .

[143]  J. Kutok,et al.  Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. , 2004, The Journal of biological chemistry.

[144]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.

[145]  M. Russo,et al.  Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site. , 2003, Oncogene.

[146]  E. Cuppen,et al.  The Wnt/beta-catenin pathway regulates cardiac valve formation. , 2003, Nature.

[147]  V. Kosma,et al.  Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. , 2001, Journal of clinical pathology.

[148]  A. Wells,et al.  Tumor invasion: role of growth factor-induced cell motility. , 2000, Advances in cancer research.

[149]  A. de Bruin,et al.  Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. , 1999, Cell adhesion and communication.

[150]  A. Børresen-Dale,et al.  E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. , 1998, The Journal of pathology.

[151]  I. Mackenzie,et al.  Rates of clearance of the epithelial surfaces of mouse oral mucosa and skin. , 1994, Epithelial cell biology.

[152]  G. Cunha,et al.  Stromal regulation of epithelial function. , 1991, Cancer treatment and research.

[153]  Atsushi Ochiai,et al.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. , 1988, Cancer research.